Down-Regulation and Clinic-Pathological Correlation of SIK-1 and SIL-1-LNC in Non-Small Cell Lung Cancer Patients.

Alireza Anvarnia Reza Panahizadeh Habib Zarredar Milad Asadi Shahriyar Hashemzadeh Mohammad Amin Vatankhah Hamed Valizadeh Mortaza Raeisi

Published in: Asian Pacific journal of cancer prevention : APJCP (2023)

Collectively, our study emphasized the role of SIK-1-LNC and SIK-1 downregulation in NSCLC oncogenesis. Additionally, SIK-1 and SIK-1-LNC, particularly the latter, have shown remarkable potential to be utilized as new NSCLC biomarkers and therapeutic targets.

Keyphrases

small cell lung cancer
advanced non small cell lung cancer
cell proliferation
bone marrow
brain metastases
risk assessment